Scott Vuocolo

1 presentation

• W89. OCCURRENCE OF URINARY RETENTION-RELATED ADVERSE EVENTS WITH XANOMELINE AND TROSPIUM CHLORIDE: RESULTS FROM THE 52-WEEK, OPEN-LABEL EMERGENT-5 TRIAL

  2026 ASCP Annual Meeting